The role of the circadian timing system on drug metabolism and detoxification: an update.
Level 5 - mechanism / opinion, no new human data
Narrative review of preclinical and mechanistic data without systematic methodology or primary human trials.
PubMed 38753451 · doi:10.1080/17425255.2024.2356167
What was done
This was a narrative review synthesizing literature on how the molecular clock regulates drug pharmacokinetics, specifically examining the circadian behavior of metabolizing enzymes and transporter families.
What was found
No quantitative data or statistical estimates were reported in the abstract. The review describes that cytochrome P450 enzymes and ABC and SLC transporter families in the intestine, liver, kidney, and blood-brain barrier exhibit circadian variation that alters drug detoxification, with noted sex-specific differences.
Why it matters
Understanding the molecular clock's control over drug metabolism provides a framework for developing chronotherapy strategies to enhance therapeutic efficacy and minimize adverse drug effects.
Limits
The abstract reports no numerical findings, study selection criteria, or sample sizes. Findings are primarily derived from preclinical models, limiting direct clinical generalizability.
Cited by
- supports The entire gut lining from the esophagus to the cecum exhibits circadian rhythmicity in transporters, pumps, and drug-absorption channels.